Literature DB >> 33788201

Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation.

Zhihan Wang1,2, Qinqin Pu2, Canhua Huang3, Min Wu4.   

Abstract

Acute and chronic lung inflammation is a risk factor for various diseases involving lungs and extrapulmonary organs. Intercellular and interorgan networks, including crosstalk between lung and brain, intestine, heart, liver, and kidney, coordinate host immunity against infection, protect tissue, and maintain homeostasis. However, this interaction may be counterproductive and cause acute or chronic comorbidities due to dysregulated inflammation in the lung. In this chapter, we review the relationship of the lung with other key organs during normal cell processes and disease development. We focus on how pneumonia may lead to a systemic pathophysiological response to acute lung injury and chronic lung disease through organ interactions, which can facilitate the development of undesirable and even deleterious extrapulmonary sequelae.

Entities:  

Keywords:  Acute lung injury; Chronic lung disease; Intercellular networks; Interorgan networks; Lung inflammation; Pneumonia

Mesh:

Year:  2021        PMID: 33788201     DOI: 10.1007/978-3-030-63046-1_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  131 in total

1.  Topographical continuity of bacterial populations in the healthy human respiratory tract.

Authors:  Emily S Charlson; Kyle Bittinger; Andrew R Haas; Ayannah S Fitzgerald; Ian Frank; Anjana Yadav; Frederic D Bushman; Ronald G Collman
Journal:  Am J Respir Crit Care Med       Date:  2011-06-16       Impact factor: 21.405

Review 2.  Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling.

Authors:  Lee J Quinton; Joseph P Mizgerd
Journal:  Annu Rev Physiol       Date:  2014-08-13       Impact factor: 19.318

3.  Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.

Authors:  G G Einarsson; D M Comer; L McIlreavey; J Parkhill; M Ennis; M M Tunney; J S Elborn
Journal:  Thorax       Date:  2016-05-04       Impact factor: 9.139

Review 4.  Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

Authors:  Christopher H Goss; Jane L Burns
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

5.  Comparison of the respiratory microbiome in healthy nonsmokers and smokers.

Authors:  Alison Morris; James M Beck; Patrick D Schloss; Thomas B Campbell; Kristina Crothers; Jeffrey L Curtis; Sonia C Flores; Andrew P Fontenot; Elodie Ghedin; Laurence Huang; Kathleen Jablonski; Eric Kleerup; Susan V Lynch; Erica Sodergren; Homer Twigg; Vincent B Young; Christine M Bassis; Arvind Venkataraman; Thomas M Schmidt; George M Weinstock
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

6.  The airway microbiome in patients with severe asthma: Associations with disease features and severity.

Authors:  Yvonne J Huang; Snehal Nariya; Jeffrey M Harris; Susan V Lynch; David F Choy; Joseph R Arron; Homer Boushey
Journal:  J Allergy Clin Immunol       Date:  2015-07-26       Impact factor: 10.793

Review 7.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

8.  Respiratory infection and the impact of pulmonary immunity on lung health and disease.

Authors:  Joseph P Mizgerd
Journal:  Am J Respir Crit Care Med       Date:  2012-07-12       Impact factor: 21.405

Review 9.  New opportunities for managing acute and chronic lung infections.

Authors:  William O C M Cookson; Michael J Cox; Miriam F Moffatt
Journal:  Nat Rev Microbiol       Date:  2017-10-24       Impact factor: 60.633

Review 10.  Role of viral respiratory infections in asthma and asthma exacerbations.

Authors:  William W Busse; Robert F Lemanske; James E Gern
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

View more
  3 in total

Review 1.  Molecular hydrogen is a potential protective agent in the management of acute lung injury.

Authors:  Yan Zhang; Jin Zhang; Zhiling Fu
Journal:  Mol Med       Date:  2022-03-03       Impact factor: 6.354

2.  Association between proteinuria trajectories and outcomes in critically ill patients with sepsis or shock.

Authors:  Raphael Monge; Charlotte Oris; Matthieu Jabaudon; Marina Braïlova; Emmanuel Futier; Vincent Sapin; Bruno Pereira; Alexandre Lautrette
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752

Review 3.  New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease-Mineral and Bone Disorder.

Authors:  Maria L Mace; Søren Egstrand; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Metabolites       Date:  2021-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.